- Recent Funding
- Investors
- TCG Crossover
TCG Crossover portfolio
TCG Crossover has 8 portfolio companies on record at Recent Funding, with 4 investments in the last 12 months.
About this page
It is a crossover fund based in Palo Alto, US, founded in 2021. It led 5 of the 8 rounds it joined. Its most recent investment on record is Soufflé Therapeutics's $135M Series B+ round in October 2026, alongside TAS Partners, Leaps by Bayer, Vida Ventures and 6 others. By category, its portfolio leans toward Health and bio (8) and Data and analytics (1). It has co-invested with Temasek, Invus and Janus Henderson Investors, most often Temasek (3 rounds).
About TCG Crossover
Fund returns
| Fund | Vintage | Size | Net IRR | TVPI | DPI | As of |
|---|---|---|---|---|---|---|
| TCG Crossover Fund | 2021 | — | 16.4% | 1.42x | 0.71x | Nov 30, 2025 |
What TCG Crossover invests in
- Health and bio · 8 · 100%
- Data and analytics · 1 · 13%
TCG Crossover recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $135M | TAS Partners, Leaps by Bayer, Vida Ventures +6 | ||
| round · $94M · lead | Viking Global Investors, The Column Group (lead) | ||
| Series B+ · $152M · lead | Kalehua Capital, EQT Life Sciences, Droia Ventures +4 | ||
| Series B+ · $287M | SilverArc Capital, Hengdian Group, Adage Capital Management +6 | ||
| Series B+ · $74M · lead | Partners Investment, Qatar Investment Authority, Piper Heartland Healthcare Capital +6 | ||
| Series B+ · $105M · lead | DaVita Venture Group, Marshall Wace, Samsara Biocapital +4 | ||
| Series B+ · $215M · lead | Tao Capital, Vertex Pharmaceuticals, Surveyor Capital +6 | ||
| Series B+ · $108M | Lilly Asia Ventures, Emerson Collective, Janus Henderson Investors (lead) +6 |
How TCG Crossover invests
TCG Crossover portfolio companies
SSoufflé Therapeutics$135MSeries B+ · Oct 2026
TTriGemX Bio$94Mround · Oct 2026
VVaderis Therapeutics$152MSeries B+ · Aug 2026
CCorxel$287MSeries B+ · Jan 2026AArbor Biotechnologies$74MSeries B+ · Mar 2025
PPathalys$105MSeries B+ · Aug 2024
SSynthekine$108MSeries B+ · Jun 2021
MMirador Therapeuticsbacker
| Company | Round with TCG Crossover | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $135M | $335M | Oct 13, 2026 Series B+ |
Health and bio |
round · $94M · lead | $94M | Oct 1, 2026 round |
Health and bio |
Series B+ · $152M · lead | $152M | Aug 11, 2026 Series B+ |
Health and bio |
Series B+ · $287M | $287M | Jan 26, 2026 Series B+ |
Health and bio |
Series B+ · $74M · lead | $289M | Mar 18, 2025 Series B+ |
Health and bio |
Series B+ · $105M · lead | $255M | Aug 20, 2024 Series B+ |
Health and bio |
Series B+ · $108M | $290M | Jan 6, 2023 Series B+ |
Health and bio |
backer | $650M | Jan 13, 2026 Series B+ |
Most frequent co-investors
TTemasek3 shared rounds · last Oct 13, 2026
IInvus2 shared rounds · last Oct 13, 2026
JJanus Henderson Investors2 shared rounds · last Oct 13, 2026
TThe Column Group2 shared rounds · last Oct 1, 2026
OOmega Funds2 shared rounds · last Aug 11, 2026
RRA Capital Management2 shared rounds · last Jan 26, 2026
TT. Rowe Price2 shared rounds · last Mar 18, 2025
SSurveyor Capital2 shared rounds · last Mar 18, 2025
VVertex Pharmaceuticals2 shared rounds · last Mar 18, 2025
SSamsara Biocapital2 shared rounds · last Aug 20, 2024
PPolaris1 shared round · last Oct 13, 2026
LLeaps by Bayer1 shared round · last Oct 13, 2026
Similar investors
DDuquesne Family Office8 companies · 4 deals in 12 mo
NNRW.BANK8 companies · 4 deals in 12 mo
TTransformation Capital8 companies · 4 deals in 12 mo
AAsabys Partners8 companies · 3 deals in 12 mo
MModi Ventures8 companies · 3 deals in 12 mo
UUK Innovation & Science Seed Fund8 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Net returns as reported by the public-pension and foundation LPs invested in each fund.
Firm profile and fund returns: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 8 rounds on Recent Funding that name TCG Crossover. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists TCG Crossover, which is a subset of its real portfolio. API: /api/v1/investors/tcg-crossover (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy